Tumor immunoescape is a well-known hallmark of cancer [1], and it is mainly caused by the activation of the programmed cell-death protein 1 (PD1)/PD-L1 signaling pathway, which inhibits T cell-mediated antitumor responses [2,3,4]. Here, PDCD1 is linked to neoplasm.